With New Phase 3 Data, Roche Claims an Edge Over Amgen and BMS Lung Cancer Drugs
Roche’s divarasib was designed offer greater potency and selectivity to KRAS G12C compared to first-generation…
With New Phase 3 Data, Roche Claims an Edge Over Amgen and BMS Lung Cancer Drugs
Roche’s divarasib was designed offer greater potency and selectivity to KRAS G12C compared to first-generation drugs in this class marketed by Amgen and Bristol Myers Squibb. The Swiss pharma company now plans to submit the data to regulators for review as a potential treatment for non-small cell lung cancer driven by this particular mutated protein….
Debunked Episode 28: A Little More Transparency, A Little More Action
Debunked Podcast co-hosts Arundhati Parmar and Samir Batra discussed some of the takeaways from UnitedHealth Group’s press event, transparency, and pharma company Lilly’s efforts to hold hospitals accountable in 340B drug discount program. The post Debunked Episode 28: A Little More Transparency, A Little More Action appeared first on MedCity News.
Hospital Networks are Becoming Targets in Cyberwarfare, and They’re Unequipped to Deal With It
The question facing hospital cybersecurity leaders today is no longer whether they will be collateral damage in a broader war; it’s how to reckon with adversaries who will target healthcare for ideological or political reasons — hackers may not have any particular interest in quick resolutions. The post Hospital Networks are Becoming Targets in Cyberwarfare,…
Why the Office of Personnel Management Needs Access to Government Employee Health Plan Claims Data
Without knowledge of the exact amount providers billed and middlemen charged in fees, OPM can’t fix payment discrepancies. The post Why the Office of Personnel Management Needs Access to Government Employee Health Plan Claims Data appeared first on MedCity News.
Hantavirus Is the Warning Signal America Should Not Ignore
Are we genuinely building long-term preparedness infrastructure, or are we repeatedly improvising our way from one outbreak cycle to the next? The post Hantavirus Is the Warning Signal America Should Not Ignore appeared first on MedCity News.
What Happens When AI Stops Answering and Starts Handling Healthcare Tasks?
Patients are trying to navigate insurance confusion, coordinate care, manage prescriptions, and understand the following steps that often feel unclear. Static chatbots were never built for this level of responsibility. Agentic AI is. Or at least that is the idea. The post What Happens When AI Stops Answering and Starts Handling Healthcare Tasks? appeared first…
A Mom Said Infant Formula Killed Her Baby. The Manufacturer Didn’t Tell the FDA.
In September 2016, a distraught mother sent infant formula maker Mead Johnson a message: “REMOVE ME FROM YOUR LIST!!!! DO NOT EMAIL OR MAIL ME ANY MORE! “It is because of your animal based pre-term artificial baby food crap that you peddle to hospital NICU’s that my son is dead from NEC.” The mother was…
New Disease Threats Follow Trump Administration’s Health Program Cuts
As beachgoers flock to water during the busy July Fourth weekend, danger could be lurking in some areas. Researchers this spring discovered flesh-eating bacteria in water in several coastal locations across New York’s Long Island, and town officials in the Hamptons vacation destination posted an alert about the findings. Eight people in Florida have been…
HealthQ Special: Caregiving in the Sandwich Generation
We’re expecting our first baby boy in end of August. And when I think about what it’s going to feel like to take care of my wife and my new son and my mom, it’s a bit overwhelming. William Morrison, from Nashville, Tennessee If you are taking care of a child and you have a…
FDA Clears First Neurostimulation Device for PTSD
Neurovalens’ Modius Spero has become the first FDA-approved neuromodulation device for treating PTSD symptoms. Veterans are set to gain access through the VA this summer. The post FDA Clears First Neurostimulation Device for PTSD appeared first on MedCity News.
